AUSTIN, Texas--(BUSINESS WIRE)--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced that it has scheduled a conference call to discuss its regulatory, clinical and corporate developments and the financial results for the first quarter ended March 31, 2007.
